Alfred Buxton
Boston, Massachusetts, 02215, United States
NCT Number: NCT04982406
This is a prospective observational study, the purpose of which is to:
1. Characterize response of the AV conduction system to TAVR with various prostheses by recording continuous His bundle electrograms during valve placement. 2. Correlate preprocedure ECG features with changes in AV nodal and infranodal conduction during placement of the valve prosthesis. 3. Correlate changes in AV nodal and infranodal conduction during the procedure with risk of developing AV conduction block after TAVR. 4. Assess the contribution of stressing the conduction system by atrial pacing prior to and following TAVR to prediction of postprocedural heart block.
Assess the correlation between new onset bundle branch block, site and degree of conduction block or delay and subsequent development of high-grade or complete AV block.
Looking for future studies?
Notify MeAll sexes
Observational
Boston, Massachusetts, 02215, United States
Study Population:
Inclusion criteria
-all patients undergoing elective TAVR Exclusion criteria -patients with permanent implanted pacemakers or ICDs prior to TAVR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Transcatheter aortic valve replacement
Time frame: 30 days following procedure
We will prospectively follow patients for the development of heart block requiring permanent pacemaker implantation, and identify factors associated with heart block following TAVR..
Beth Israel Deaconess Medical Center
Other
Acronym: TAVR-HBE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04489095
Aortic Insufficiency, Aortic Stenosis
Detroit, Michigan, United States
View Trial DetailsNCT06055751
Aortic Stenosis, Aortic Valve Disease
Kansas City, Missouri, United States
View Trial DetailsNCT05235555
Aortic Stenosis, Aortic Valve Disease
Naples, Italy
View Trial DetailsNCT04454177
Aortic Stenosis, Aortic Valve Disease
Hangzhou, Zhejiang, China
View Trial Details